RxDoctor Payments Data

Neelesh Mehendale, MD

Otolaryngology · Frisco, TXNPI 1235134271

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Acclarent, Inc at 38.1% of the total.

$5,917in general payments, 2019–2025

Across 104 payments — averaging $56.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$2K
  • Inspire Medical Systems, Inc.$1K
  • Stryker$681
  • Medtronic$403
  • Sanofi$395
  • Aerin Medical Inc.$204
  • plus $861 from 15 others
$181,837in research payments, 2019–2025

Across 40 payments — averaging $4545.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$106K
  • Stryker$75K

What the payments were for

  • Consulting fees$1,68829%
  • Travel & lodging$67511%
  • Food & beverage$3,46859%
  • Education$871%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,917 in reported general payments places this provider in the 80th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$188,455
Medicare patients
275
Services billed
2,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl50$1,692
Ipratropium Bromide44$1,641
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,171
Omeprazole87$932
CefuroximeCefuroxime Axetil43$930
Fluticasone Propionate54$796
Mupirocin46$382
Cefdinir17$336
Montelukast Sodium37$335
Methylprednisolone43$255
Acetaminophen-CodeineAcetaminophen With Codeine28$221
Ondansetron OdtOndansetron13$74
Prednisone15$61
Diazepam11$14

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →